Office of Rare Diseases (ORD) [clinicaltrials_resource:d7e78eb02c77e8947b41fa25121f822a]
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) [clinicaltrials:NCT00004306]Characteristics of Episodic Ataxia Syndrome [clinicaltrials:NCT00266760]Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00319878clinicaltrials:NCT00414648clinicaltrials:NCT00466843Natural History of Apparent Mineralocorticoid Excess Syndrome [clinicaltrials:NCT00474942]
collaborator [clinicaltrials_vocabulary:collaborator]
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) [clinicaltrials:NCT00004306]Characteristics of Episodic Ataxia Syndrome [clinicaltrials:NCT00266760]Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00319878clinicaltrials:NCT00414648clinicaltrials:NCT00466843Natural History of Apparent Mineralocorticoid Excess Syndrome [clinicaltrials:NCT00474942]Examining Genetic Differences Among People With 21-Hydroxylase Deficiency [clinicaltrials:NCT00542841]Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers [clinicaltrials:NCT00617292]Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia [clinicaltrials:NCT00694525]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Study of Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes at High Risk of Kidney or Heart Disease [clinicaltrials:NCT00004266]Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome [clinicaltrials:NCT00004274]Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome [clinicaltrials:NCT00004275]Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections [clinicaltrials:NCT00004276]Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection [clinicaltrials:NCT00004278]Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria [clinicaltrials:NCT00004284]Phase II Randomized Study of Standard Vs High Amount of Hemodialysis Using Low Vs High Flux Dialyzer Membranes for End Stage Renal Disease [clinicaltrials:NCT00004285]Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy [clinicaltrials:NCT00004286]Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis [clinicaltrials:NCT00004287]Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis [clinicaltrials:NCT00004288]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus [clinicaltrials:NCT00004297]Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis [clinicaltrials:NCT00004300]Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) [clinicaltrials:NCT00004306]Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome [clinicaltrials:NCT00004311]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency [clinicaltrials:NCT00004313]Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease [clinicaltrials:NCT00004314]Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis [clinicaltrials:NCT00004316]clinicaltrials:NCT00004317Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia [clinicaltrials:NCT00004327]Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I [clinicaltrials:NCT00004328]Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly [clinicaltrials:NCT00004332]Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I [clinicaltrials:NCT00004333]Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders [clinicaltrials:NCT00004341]Purification of Testis-Stimulating Factor in Precocious Puberty [clinicaltrials:NCT00004344]Study of Protein Translocation in Patients With Beta-Oxidation Disorders [clinicaltrials:NCT00004348]Evaluation of Fanconi Syndrome and Cystinosis [clinicaltrials:NCT00004350]Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes [clinicaltrials:NCT00004351]Study of Homocysteine Metabolism in Homocystinuria [clinicaltrials:NCT00004356]Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita [clinicaltrials:NCT00004359]Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus [clinicaltrials:NCT00004360]Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects [clinicaltrials:NCT00004361]Study of Novel Types of Familial Diabetes Insipidus [clinicaltrials:NCT00004364]Study of Pituitary Size and Function in Familial Dwarfism of Sindh [clinicaltrials:NCT00004365]Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction [clinicaltrials:NCT00004366]Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis [clinicaltrials:NCT00004368]Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety [clinicaltrials:NCT00004373]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00004376]Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis [clinicaltrials:NCT00004380]Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia [clinicaltrials:NCT00004381]
source [clinicaltrials_vocabulary:source]
Office of Rare Diseases (ORD) [clinicaltrials_resource:d7e78eb02c77e8947b41fa25121f822a]
Bio2RDF identifier
d7e78eb02c77e8947b41fa25121f822a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d7e78eb02c77e8947b41fa25121f822a
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:d7e78eb02c77e8947b41fa25121f822a
title
Office of Rare Diseases (ORD)
@en
type
label
Office of Rare Diseases (ORD) [clinicaltrials_resource:d7e78eb02c77e8947b41fa25121f822a]
@en